chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a Medical assiostant referring to unspecified patients of unknown genders. No information regarding the patients' medical history, concurrent conditions or concomitant therapies was provided. On an unknown date, the patients were vaccinated with improperly stored dose of VAQTA Lot number "M039202" with expiration date on 11-MAR-2018 (strength and route of administration were not reported) for prophylaxis, however no adverse effects reported. It was reported that the vaccines were exposed to temperature of 22 grades F (Fahrenheit) for a time frame of 12 hours. There were no previous temperature excursions for vaccines.  The temperature excursion was recorded by a data logger. There was no product quality complaint involved. This is one of the several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1703USA009836: US-009507513-1703USA006985: US-009507513-1703USA006983: US-009507513-1703USA006984:
Chills and muscle weakness that started on 2/13 PM and then mom suffered a basal ganglia stroke on 2/14 PM.
Excessive menstual issues, on going vaginal bleeding began shortly after vaccinated & continue still weeks after
Acid indigestion, just tired.  One incident of being a little short of breath.  Checked my oximeter and my blood oxygen level was good and heart rate was good.  Oxygen 95  and heart rate 70.
Admitted to Hospital on 2/19/22 for weakness and confusion.  Diagnosed with COVID-19.  Discharged from hospital on 2/21/22.  Limited information provided from hospital.
On 9/21/21 patient administered dose of Janssen vaccine with expiration date of 9/19/21.
After two months from the vaccines and flu shot she started losing her memory very fast, she got diagnosed with Lupus. She started losing her memory faster she couldn't maintain keeping a job. She eventually tested positive for Alzheimer's and dementia. Had to get hospitalized multiple times and now has to live at a nursing home.
Severe pain at injection site in RIGHT shoulder. Pain still continues to this reporting date. My shoulder was injured because the flu shot was given too high. I have received a cortisone shot and physical therapy to treat this injury.
Needle Malfunction, less that 50% of original dose administered, 2nd dose given w/ no problem
Patient hospitalized for echocardiogram due to nonrheumatic aortic valve stenosis, atrial fibrillation on 12/2/21. Patient presented to the ED on 12/4/21 for hematoma. She then had a TAVR on 12/21/21. These visits are within 6 weeks of receiving COVID vaccination.
On 3/12/14, 16 yo M presented to clinic for well adolescent visit. During visit, pt was ordered second injection of HPV vaccine IM (GARDASIL) [IMM75] (Order 175668570). First dose was administered on 9/9/13 with no documentation of adverse effects. At 0929, after obtaining verbal parental consent, 0.5 mL HPV Quadrivalent vaccine was injected into right deltoid (NDC: 0006-4045-41; Manu: Merck & Co. Inc; lot #J012212; exp: 2/18/2016). Pt was instructed to lay flat for 15 minutes per protocol. After 15 min, NA returned to room to assess pt. At that time, pt reported not feeling well. MD notified & pt exam found some arm swelling. Pt further reported elbow & back pain. Pt was administered diphenhydramine 25 mg PO & held in observation x 30 minutes. After observation, pt was administered a second dose of diphenhydramine 25 mg PO. Pt was then released in the care of his parent. On 3/12, pt's allergy profile was updated to include Gardasil (H Papillomavirus Vac,qval (pf)) (rxn: Swelling). Non-preventable event. Event reported to VAERS.
Hospitalization for Sepsis due to UTI, COVID-19 infection, acute hypoxic respiratory failure, normocytic anemia on dates 9/24/2023- 9/25/2023..  Treated with dexamethasone, vitamin C 1,000 mg PO daily, vitamin D 25 mcg PO daily, zinc 50 mg PO daily.
metallic taste in her mouth; difficulty swallowing; This is a spontaneous report from a non-contactable consumer (patient herself). A 66-year-old female patient received BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- EL9262) via an unspecified route of administration in left arm on 27Jan2021 14:00 as 1st dose single (at the age of 66-years-old) for COVID-19 immunization. The patient was not pregnant at the time of vaccination. Facility where the most recent COVID-19 vaccine was administered was reported as Other. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not diagnosed with COVID-19 prior to vaccination. Patient has not been tested for COVID-19, since the vaccination. Patient medical history was not reported. Patient had no allergies to medications, food, or other products. The concomitant medications included lisinopril; amlodipine besilate; esomeprazole magnesium (NEXIUM); betacarotene, bioflavonoids nos, biotin, calcium ascorbate, calcium pantothenate, chromium amino acid chelate, colecalciferol, cyanocobalamin, ferrous fumarate, folic acid, magnesium oxide, nicotinamide, oenothera biennis oil, panax ginseng, riboflavin phosphate, royal jelly, thiamine hydrochloride, tocopheryl acid succinate, zinc oxide (WOMEN'S MULTIVITE). On 27Jan2021 15:00, about 45 minutes after receiving the vaccine patient noticed a metallic taste in her mouth and had difficulty swallowing. The difficulty swallowing lasted about an hour. The metallic taste lasted for a day. The patient did not receive any treatment for the adverse events. On 27Jan2021 16:00, the outcome of the event of swallowing difficulty and on 28Jan2021 of the event metallic taste in her mouth was recovered.   No follow-up attempts are possible. No further information is expected.
Several children, ages 6-16, vax w/ booster dose; complained of stinging at inject site;  stinging lasted for 1 minute.
during our covid site visit on 12.15.22, it was discovered that we had a pfizer batch in the frig past BUD date. During the investigation they went back through all the covid injections that were given and saw this patients lot number was given past BUD date. patient has been contacted and revaccination was offered. manufacture was notified and reports were filed pending outcome.
Very painful in arm, worse than the 1st shot.  By the evening I have a pounding headache.  Headache just gets worse through the night. I start to experience dizzyness and intense nausea. Low-grade fever. Hard to move around and so collapsed several times when I tried to move.
pt recv vax & 24 to 36 hr later devel hives the size of a silver dollar;tx w/DPH & the hives subsided p/1wk;
Temperature 99.5 - usually run in 96 to 97 range. Body aches. Eyelids swelled and were red.
Clotting, similar to Covid-19 Amyloid clots, have been found by a Surgeon, and surgically removed; This spontaneous report was received from  an unspecified reporter and refers to a female patient of unknown age.  The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.  On an unknown date, the patient started therapy with quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) intramuscular injection, , administered for prophylaxis (strength, dose description, lot #, expiry date, and route of administration were not provided). It was reported that on an unknown date the patient  experienced clotting, similar to Covid-19 Amyloid clots,it was found by a Surgeon, and surgically removed. At the time of reporting, the outcome of the event  was not known.   The causal relationship between blood clot and quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) was unknown.   Upon internal review, the event of blood clot was determined to be medically significant.
Employee reported she felt a "burning sensation in my chest and a few hours later passed out and hit my head".  Employee stated that she went to Emergency Room after mid-night for evaluation; no abnormality found; she was sent home. (Note that this report is submitted on behalf of another RN who was the administrator for this patient/employee)
Itching started approx 2 hours after administration. Developed redness, swelling, pain and heat, progressively getting worse.
While I did have a port in my jugular for chemo a few weeks after receiving Moderna shot I presented with a 3"-4" blood clot in my right jugular. Every doctor/surgeon stated they had never seen a clot this big from a port. I was rushed to ER and then spent one week in ICU on IV blood thinners. I was sent home and kept on blood thinners for the next 6 months.
1. extreme chills (but no fever) beginning at 3:30 pm, 2.  nausea beginning at 10 pm followed by one episode of  3. vomiting at 11:00 pm, nausea continued throughout the evening,  4. severe body aches beginning early the next morning -  5. severe pain in spine caused inability to walk or move without pain  for two days (pain upon moving was unbearable- to realize later I had some inflammation in my spine as a result of vaccine). 6. migraine  7. spinal pain and migraines have taken two months to return to pre-vaccine levels (I had NO spinal pain prior to vaccination)
Vaccinated at 610am. Mild myalgias, pain at injection site, and headache starting around around 430pm  when I woke up for work. Severe myalgias, fatigue, worsening headache, pain at injection site and chills noticed around 9pm on 1/8/21 continued until I went to sleep. I slept from 1am 1/9/21 to 230pm 1/9/21. Currently 4pm and experiencing mild generalized myalgias, mild headache, left shoulder and injection site pain and fatigue.
Approximately, 8 days after vaccination shot, I developed a rash (red, warm,  swollen, occasionally itchy) at injection site.  Roughly 3 in tall, 2 in. wide.  Sort of egg-shaped.  On 9th day (today) it seems somewhat less red and swollen, but still present.
Started spiking a fever and getting nauseated around 7:00 PM. This was followed by severe chills for several hours. Diarrhea and vomiting started about 9:00 PM. Upper abdominal pain in the right/mid quadrant occurred for several hours before and after vomiting and diarrhea. Experienced severe body aches, joint pain, and continuous aching in left hand and foot. Had a headache for 2 days. Fever climbed to 104 degrees by 11:00 PM on 4/5/21, and 800 mg. of ibuprofen was taken to reduce fever. Remained very weak throughout the night. Continued to feel nauseated, running a moderate fever (up to 101 degrees), severe body aches and weakness throughout the 6th. Woke up feeling better by the morning of the 7th.
Sore arm on side of injection Tender armpit on side of injection Woke up with fever day after injection Pain in middle of back similar day after injection
Moderna COVID-19 Vaccine EUA Red rash around injection site, spreading to about 6" in diameter, which is raised, hot, and itchy, lasting more than 2 weeks.
heat in the chest during administration; increased tachycardia; swollen legs; shaking; Dizziness; Sweating; low grade fever; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (heat in the chest during administration), TACHYCARDIA (increased tachycardia), PERIPHERAL SWELLING (swollen legs), TREMOR (shaking) and DIZZINESS (Dizziness) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced CHEST DISCOMFORT (heat in the chest during administration), TACHYCARDIA (increased tachycardia), PERIPHERAL SWELLING (swollen legs), TREMOR (shaking), DIZZINESS (Dizziness), HYPERHIDROSIS (Sweating), PYREXIA (low grade fever) and NAUSEA (Nausea). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) at a dose of 1 dosage form. At the time of the report, CHEST DISCOMFORT (heat in the chest during administration), TACHYCARDIA (increased tachycardia), PERIPHERAL SWELLING (swollen legs), TREMOR (shaking), DIZZINESS (Dizziness), HYPERHIDROSIS (Sweating), PYREXIA (low grade fever) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.    Reporter did not allow further contact
Coughing extremely, vomiting. Awake at night, coughing uncontrollably.
DOS 12/20 7 day HX of erythema, lesion, cellulitis like TX: Cephalexin/BACTROBAN.
Information has been received from a Registered Nurse (R.N) concerning her 4 year old son with no pertinent medical history and no known drug allergies/drug reactions who was vaccinated with a dose of MMR II at one year of age (February 2006). There was no concomitant medication. It was reported that since then (approximately February 2006) the patient has required speech therapy and occupational therapy. It was reported that he also experienced a fever when he initially received the vaccine (February 2006). The patient sought unspecified medical attention. It was reported that at the time of this report (26-MAR-2009) he was "catching up" with his speech. There were no laboratory diagnostic test performed. It was reported that on an unspecified date the patient had recovered from the fever and was recovering regarding his speech. Additional information has been requested. Information has been received from a pediatric nurse on 26-MAR-2009. She reported concern with the "unavailability of the monovalents (vaccinesa)."
My COVID-19 symptoms started on 03/12/2023 in the afternoon at 03:00PM. I had a slight sore throat. The next day I had low grade fever and tired. I tested with a home COVID-19 kit at 11:00AM on 03/13/2023 which was positive. I called my doctor and they wanted a virtual care but I decline because I wanted to see my doctor in person. I scheduled an appointment to go to the urgent care on 03/13/2023. At the urgent care they prescribed PAXLOVID for 5 days.
Information has been received from a registered nurse concerning a 22 year old female patient with no pertinent medical history and no allergies who on 27-JUL-2010 was vaccinated intramuscularly with the first dose of GARDASIL (lot # 666118/1539Y). There was no concomitant medication. Subsequently, the patient developed an injection site reaction. The patient developed pain and swelling at the site than continued to persist. Unspecified medical attention was sought via phone call. There were no laboratory diagnostics studies performed. The patient's pain at the site and swelling at the injection site persisted. Additional information has been received from the registered nurse indicated the reaction was "0.25 cm area of edema at injection site" and the symptoms were resolving. The patient was fine. Follow up information has been received from the registered nurse concerning the 22 year old female patient with no pre-existing allergies, birth defects or medical conditions who on 27-JUL-2010 was vaccinated IM in the left deltoid with the first dose of GARDASIL (lot number 666118/1539Y). On 27-JUL-2010 the patient experienced swelling, redness and pain at injection site. Follow up information has been received from the registered nurse indicated that the patient recovered within one week of symptoms. Additional information is not expected.
8/20/20 - Bruising on upper arm, soreness, tenderness 8/21/20 - More Bruising - larger area - red faint line on upper arm 8/22/20- Bruise encompasses 1/4 arm - large prominent red line 5-6" lengthwise, swelling, pain, soreness, tenderness
08/19/2005 fever, diarrhea, loss of appetite began, Fever continued up to 103.6F. Injection site on right thigh hard and swollen. Symptoms subsided by 08/24/2005, treated with Tylenol and warm compresses to thigh.
Dizziness, fever, nausea, vomiting, bad swelling of hands, feet and face. Swelling is intermittent. Nausea over 7 days. Episodes of blurred vision, hands shaky.
This spontaneous report as received from a medical assistant refers to a 6 years old female patient. On 16-JUL-2013, the patient was vaccinated with the first dose of VARIVAX subcutaneous , and subsequently on 16-AUG-2013 the patient was vaccinated with the second dose of VARIVAX subcutaneous. No adverse effect reported. Additional information has been requested.
seems to have an autoimmune response; She has hives wrapped around her entire left ankle; Other medical history: Graves disease; Other medical history: Graves disease; this is her ankle is swollen and not very comfortable; this is her ankle is swollen and not very comfortable; This is a spontaneous report from a contactable other health professional (patient).  A 57-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1685, pending clarification), via an unspecified route of administration (at the age of 57-year-old) on 12Jan2021 (also reported as 19Jan2021, pending clarification) at a single dose for COVID-19 immunization. Medical history included Graves disease and COVID-19. Concomitant medication included metoprolol. Patient completed the report online at Pfizer, but does not have a reference number for that report. She is scheduled to get second shot tomorrow, however, she seems to have an autoimmune response. She has hives wrapped around her entire left ankle on 22Jan2021. She wants to know if she should get second dose or not. She works in a nursing home. She has been noticing here and there little dots of hives that were not a big deal and this is her ankle is swollen and not very comfortable. The patient would like to know if it would be safe for her to have the second dose given her autoimmune response to the first dose. No treatment received for the event "She has hives wrapped around her entire left ankle". The outcome of the events was unknown. The patient was not pregnant. Facility type vaccine was Nursing Home/Senior Living Facility. No other vaccine in four weeks. Not COVID tested post vaccination.  Information on the lot/batch number has been requested (clarification).
A report has been received from a health professional via medical representative, concerning a 65 year old, female patient. The patient's concurrent diseases included reactive airway disease. Concomitant medications included salbutamol, anabolic steroids and other respiratory system products. During Oct-2012, the patient received nasal FLUMIST. It was reported that the patient wheezed for two days after vaccination. The outcome of the event of wheezing was unknown. The report was considered to be non-serious by the reporting health professional. Summary of follow-up information received by AstraZeneca/MedImmune on 28-Nov-2012 from health professional: patient history and concomitant medications added.
suspected vaccination failure; bout of shingles.; This case was reported by a consumer via  interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.  The patient's past medical history included chickenpox (had as a kid) and shingles.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was recovering/resolving.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient had reported for him/herself. The age at vaccination was not reported. The patient had chickenpox as a kid as the vaccine was not available then, also had shingles too. About 3 to 4 years ago, the patient was offered the Shingles vaccine and was ensured that the fact he/she had both chickenpox and shingles would not make a difference.  After receiving Shingles vaccine, the patient was getting over a bout of shingles at the time of reporting. The patient stated that, obviously, the vaccine was not always effective. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation were not provided.
Child was given a Hepatitis A vaccine at 9:30 a.m. and then had a syncopal episode. Ammonia inhalant was administered and the child regained consciousness. Child was given juice box and a cold pack applied. Supervisor was called in to the room. Child was giving delayed responses to questions, was very fatigued and physically weak when asked to squeeze Nurse' hand. Vital signs taken at 9:45 a.m., blood pressure 110/72, pulse 60 bpm. At 9:45 blood pressure was 118/80, pulse 60. EMS was called at 10 a.m. EMS arrived at 10:10 a.m. and stated they would transport child to hospital. Child's mother was present and stated she would follow EMS to hospital. Medical director notified.
Symptoms were intense ear pain and left facial discomfort.  Diagnosis was trigeminal neuralgia .
Severe red swollen area nausea malaise fever to 102 for 5 days.
Low grade fever for over a week. Followed with dizziness. The dizziness hasn?t stopped. He?s been to a number of specialist. They cannot rule out adverse affect of Covid vaccine.
1st dose 2 years ago; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 78-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received 2 years ago prior to the reporting).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 21-SEP-2022 Reporter's Comment: The reporter wanted to know what should he do. The reporter did consent to follow up via email. Additional supportive information: Till the time of reporting, the patient did not receive the 2nd dose, which led to incomplete course of vaccination.
Pt. states that after receiving the 2nd dose of Phizer 01/27/2021, started experiencing symptoms 07/27/2021 of Elevated Liver Enzymes. Primary recommendation for Follow-Up re-testing 2 weeks (Results = Normal) 08/11/2021.
TWINRIX given per accelerated dosing due to departure date. At appt. for 3rd dose he stated he had been experiencing dizziness and wondered if vaccine could cause that. On 5/21/13 he called in and said he felt certain the vaccine had caused his "vertigo". Stated dizziness started about 1 week after 1st dose, that it comes and goes. Denies any previous episodes of dizziness. Has seen PCP and stated that she doesn't feel like the vaccine would have caused it.
Macular rash on trunk and upper extremities 14 days after MMR vaccine no Temp, no cervical adenopathy- states flu like symptoms 2 days prior to rash with shortness of breath.